Non-Covered Medications
Prescription medications removed from the TRICARE pharmacy benefit program.
Drug Class | Products not covered/removed from TRICARE Formulary | Formulary Alternatives | Effective Date of Change |
---|---|---|---|
TIBs | adalimumab (Cordavis brand of Humira) |
|
11/13/2024 |
Acne Agents: Topical Acne and Rosacea |
clindamycin 1.2%, adapalene 0.15%, and benzoyl peroxide 3.1% topical gel (Cabtreo) |
|
08/28/2024 |
Pain Agents: NSAIDs |
oxaprozin 300 mg capsules (Coxanto) |
|
08/28/2024 |
Cardiovascular Agents Miscellaneous | colchicine low dose (LODOCO 0.5 mg tablets |
|
6/12/2024 |
PAH: PDE-5 Inhibitors | sildenafil 10 mg/mL oral suspension (Liqrev) |
|
02/28/2024 |
Binders Chelators Antidotes |
trientine tetrahydrochloride tabs (Cuvrior) |
|
02/28/2024 |
Sleep Disorders: Insomnia Agents | zolpidem 7.5 mg caps |
|
02/28/2024 |
Ophthalmic Dry Eye | Agentsloteprednol etabonate 0.25% ophthalmic suspension (Eysuvis) |
|
11/22/2023 |
Diureticsfurosemide SC injection | (Fuoscix) |
|
08/30/2023 |
Benign Prostatic Hyperplasia Agents; 5-alpha Reductase Inhibitors | finasteride/ tadalafil (Entadfi) |
|
05/31/2023 |
Nasal Allergy Agents: Corticosteroids | olopatadine 665 mcg /mometasone 25 mcg nasal spray (Ryaltris Nasal Spray) |
|
05/31/2023 |
Skeletal Muscle Relaxants | baclofen oral solution (Lyvispah) |
|
03/01/2023 |
Acne Agents: Topical Acne & Rosacea | benzoyl peroxide 5% cream (Epsolay) |
|
03/01/2023 |
Nephrology Agents Miscellaneous | budesonide (Tarpeyo) |
|
11/30/2022 |
Narcotic Analgesics and Combinations | celecoxib/tramadol (Seglentis) |
|
11/30/2022 |
Anticholinergics-Antispasmodics | glycopyrrolate (Dartisla ODT) |
|
11/30/2022 |
Endocrine Agents Miscellaneous | levoketoconazole(Recorlev) |
|
11/30/2022 |
Diuretics | torsemide (Soaanz) |
|
11/30/2022 |
Acne Agents: Topical Acne & Rosacea |
tretinoin 0.1%/benzoyl peroxide3% topical cream(Twyneo) |
|
11/30/2022 |
Pain Agents: NSAIDs | Celecoxib oral solution (Elyxyb) |
|
08/24/2022 |
Antianxiety Agents: Benzodiazepines | Lorazepam ER capsule (Loreev XR) |
|
06/15/2022 |
Migraine Agents | Dihydroergotamine mesylate nasal spray (Trudhesa) |
|
06/15/2022 |
Antilipidemic-1s | Rosuvastatin/ ezetimibe (Roszet) |
|
06/15/2022 |
Anticonvulsants-Antimania Agents | Levetiracetam (Elepsia XR) |
|
06/15/2022 |
Corticosteroids-Immune Modulators: High Potency | Clobetasol propionate 0.05% lotion metered dose pump (Impeklo) |
|
06/15/2022 |
Psoriasis Agents | Calcipotriene/ betamethasone dipropionate 0.005% /0.064% topical cream (Wynzora) |
|
06/15/2022 |
GI-1 Agents | Budesonide ER 9 mg capsules (Ortikos) |
|
06/02/2021 |
Corticosteroids | Dexamethasone 20 mg tables (Hemady) |
|
06/02/2021 |
Pulmonary I Agents Inhaled Corticosteroids (ICS) | Fluticasone propionate dry powder inhaler oral (ArmonAir Digihaler) |
|
06/02/2021 |
Pulmonary I Agents ICS/Long-Acting Beta Agonists (LABA) | Fluticasone propionate / salmeterol dry powder inhaler oral (AirDuo Digihaler) |
|
06/02/2021 |
Calcium Channel Blockers | Levamlodipine (Conjupri) |
|
06/02/2021 |
GI-2 Agents | Metoclopramide nasal spray (Gimoti) |
|
06/02/2021 |
Topical Psoriasis Agents | Calcipotriene 0.005% Betamethasone 0.064% Suspension (Taclonex, Generic) | Scalp Psoriasis:
|
02/24/2021 |
High-Potency Topical Corticosteroids | Halcinonide 0.1% topical solution (Halog) |
|
2/24/2021 |
Acne Agents: Topical Acne and Rosacea | Tazarotene 0.045% lotion (Arazlo) |
|
2/24/2021 |
Pain Agents Class; NSAIDs Subclass | Consensi (Amlodipine-celecoxib) |
|
8/26/2020 |
Pain Agents Class; NSAIDs Subclass |
|
NSAIDs: celecoxib, diclofenac, indomethacin, meloxicam, naproxen, (also includes other NSAIDs) | 8/26/2020 |
Pain Agents Class; NSAIDs Subclass | Duexis tablets (ibuprofen-famotidine) |
|
8/26/2020 |
Pain Agents Class; Pain Topical Subclass |
|
|
8/26/2020 |
Pain Agents Class; Pain Topical Subclass | ZTlido (lidocaine 1.8% patch) | Lidocaine 5% patch | 8/26/2020 |
Pulmonary: Short Acting Beta-2 Agonists (SABA) | ProAir Digihaler (albuterol dry powder inhaler) |
|
8/26/2020 |
Acne Agents: Topical Acne and Rosacea | Enzoclear (benzoyl peroxide 9.8% foam) |
|
8/26/2020 |
Anti-Infectives: Miscellaneous | Talicia (omeprazole magnesium-amoxicillin-rifabutin) |
|
8/26/2020 |
Rapid Acting Insulins | Insulin plus niacinamide (Fiasp) |
|
07/01/2020 |
Pulmonary-2 Agents: COPD | Formoterol/aclidinium (Duaklir Pressair) |
|
06/10/2020 |
Migraine Agents: Triptans | Sumatriptan nasal spray (Tosymra) |
|
06/10/2020 |
GI2 Agents: CIC and IBS-C | Tegaserod (Zelnorm) |
|
06/10/2020 |
PDE-5 inhibitor |
|
|
06/03/2020 |
ADHD | Methylphenidate ER sprinkle capsules (Adhansia XR) |
|
03/04/2020 |
High-Potency Topical Corticosteroids |
|
|
03/04/2020 |
High-Potency Topical Corticosteroids | Halcinonide 0.1% ointment (Halog) |
|
03/04/2020 |
High-Potency Topical Corticosteroids |
|
|
03/04/2020 |
PPIs |
|
|
11/28/2019 |
High-Potency Topical Corticosteroids | Halobetasol propionate 0.05% foam (Lexette brand) |
|
10/01/2019 |
Diabetes Non- Insulin Drugs – Biguanides Subclass | Metformin ER gastric retention 24 hours (Glumetza) |
|
10/01/2019 |
Pain Agents – Combinations | Naproxen / Esomeprazole (Vimovo) |
|
10/01/2019 |